Dark Streaming/Mobile Old Site Home Products Help Contact Us Your Account System Status
Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS
12:56:03 EDT Tue 22 Apr 2025
Enter Symbol
or Name
USA
CA



Forgot password?
Trouble logging in?
Login ID:
Password:
Save

V:RKV - Rakovina Therapeutics Inc. - https://www.rakovinatherapeutics.com
Sym-XBid - AskLastChg%ChVol$Vol#TrOpen-Hi-LoYear Hi-LoLast TrNewsDelay
RKV - V  31.00.045·0.05109.00.05650.131490.05  0.055  0.0450.23  0.04512:20:4908:3015 min RT 2¢
TSX-V - V31.00.045·0.05109.00.05582.629230.05  0.05  0.050.23  0.04512:20:4915 min
NEO ATS - U 0.0527.0190.045  0.05  0.04511:38:3715 min
Omega - O 0.0522.0150.05  0.055  0.0511:38:3715 min
CX2 - H 0.0517.0150.05  0.05  0.0511:38:3715 min
CXD - D 0.051.46    Apr 1115 min
TriAct - M 0.050.041    15 min

Recent Trades - Last 10 of 49
Time ETExPriceChangeVolumeBuyerSellerMarkers
12:20:49V0.05 1,00088 Credential1 AnonymousK
12:17:18V0.05 1,00079 CIBC1 AnonymousK
12:10:35D0.05 8407 TD Sec7 TD SecE
12:10:35V0.05 9,0007 TD Sec1 AnonymousK
11:40:56V0.05 20,00080 National Bank1 AnonymousK
11:38:37U0.05 4,0007 TD Sec2 RBCK
11:38:37U0.05 5,0007 TD Sec2 RBCK
11:38:37O0.05 4,0001 Anonymous2 RBCK
11:38:37H0.05 5,0007 TD Sec2 RBCK
11:32:07M0.05 417 TD Sec7 TD SecE

Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS

Recent Bulletins
Date ETSymbolPriceTypeHeadline
2025-04-22 08:30C:RKV0.05News ReleaseRakovina Therapeutics Congratulates Scientific Advisor Dr. Artem Cherkasov on Global Recognition for Breakthrough AI Innovation in Drug Discovery
2025-03-25 18:47C:RKV0.115News ReleaseRakovina abstracts to be presented at research meeting
2025-03-12 16:57C:RKV0.13News ReleaseRakovina receives batch of AI-generated ATR compounds
2025-02-26 17:03C:RKV0.15News ReleaseRakovina talks up partnership with Variational
2025-02-06 17:27C:RKV0.19News ReleaseRakovina continues work on AI drug discovery
2025-01-30 18:22C:RKV0.19News ReleaseRakovina Therapeutics begins trading on FSE
2025-01-29 08:30C:RKV0.195News ReleaseRakovina Therapeutics to Participate in BioInnovate UBC Annual Conference
2025-01-22 11:00C:RKV0.19News ReleaseRakovina sees U.S. earmark $500B (U.S.) for AI spending
2025-01-13 17:46C:RKV0.18News ReleaseRakovina sets shortlist of molecules targeting ATR
2025-01-06 17:54C:RKV0.185News ReleaseRakovina synthesizes drug candidates under AI platform
2024-12-31 16:54C:RKV0.19Shares for DebtRakovina Therapeutics 203,400 shares for debt
2024-12-20 17:10C:RKVPrivate PlacementRakovina 50-million-share private placement
2024-12-19 17:15C:RKV0.15News ReleaseRakovina review 2024, looks ahead to 2025
2024-12-18 04:40C:RKV0.13News ReleaseRakovina to issue shares for $20,500 in interest
2024-12-13 19:42C:RKV0.11News ReleaseRakovina closes $3-million private placement
2024-12-03 07:35C:RKV0.08News ReleaseRakovina Therapeutics Announces Presentation at the 13th Annual Tumour Models London Summit
2024-12-03 03:30C:RKV0.08News ReleaseRakovina increases private placement to $3-million
2024-11-29 21:28C:RKV0.09SEDAR Interim Financial StatementsSEDAR Interim Financial Statements
2024-11-29 21:28C:RKV0.09SEDAR Interim MD & ASEDAR Interim MD & A
2024-11-29 20:40C:RKV0.09News ReleaseRakovina Therapeutics Announces 2024 Q3 Financial Results and Provides Corporate Update